Interpreting big-data analysis of retrospective observational data

Por Huizinga, Tom W J, Knevel, Rachel
Publicado no Lancet Rheumatol (2020)

Tweaking Microtubules to Treat Scleroderma

Por van Laar, Jacob M, Huizinga, Tom W. J
Publicado em 2005

Autoimmune Responses in the Rheumatoid Synovium

Por Toes, Rene E. M, Huizinga, Tom W. J
Publicado em 2009

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

Por Emery, Paul, Sebba, Anthony, Huizinga, Tom W J
Publicado em 2013

The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA

Por Yarwood, Annie, Huizinga, Tom W. J., Worthington, Jane
Publicado no Rheumatology (Oxford) (2016)

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

Por Huizinga, Tom W. J., Torii, Yoshifumi, Muniz, Rafael
Publicado no Rheumatol Ther (2020)

Genetics of rheumatoid arthritis: what have we learned?

Por Bax, Marieke, van Heemst, Jurgen, Huizinga, Tom W. J., Toes, Rene E. M.
Publicado em 2011

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply

Por Markusse, Iris M., Lems, Willem F., Huizinga, Tom W.J., Allaart, Cornelia F.
Publicado no Arthritis Res Ther (2015)

Dosing down with biologic therapies: a systematic review and clinicians’ perspective

Por Edwards, Christopher J, Fautrel, Bruno, Schulze-Koops, Hendrik, Huizinga, Tom W J, Kruger, Klaus
Publicado no Rheumatology (Oxford) (2018)

Dosing down with biologic therapies: a systematic review and clinicians’ perspective

Por Edwards, Christopher J, Fautrel, Bruno, Schulze-Koops, Hendrik, Huizinga, Tom W J, Kruger, Klaus
Publicado no Rheumatology (Oxford) (2017)

Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis

Por Boer, Aleid C., Huizinga, Tom W.J., van der Helm - van Mil, Annette H.M.
Publicado no Ann Rheum Dis (2018)

How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions

Por Manaï, Meriem, van Middendorp, Henriët, Veldhuijzen, Dieuwke S., Huizinga, Tom W.J., Evers, Andrea W.M.
Publicado no Pain Rep (2019)

Abnormal Brain Diffusivity in Patients with Neuropsychiatric Systemic Lupus Erythematosus

Por Bosma, Gerlof P. Th., Huizinga, Tom W. J., Mooijaart, Simon P., van Buchem, Mark A.
Publicado no AJNR Am J Neuroradiol (2003)

Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial

Por Dougados, Maxime, Huizinga, Tom W. J., Choy, Ernest H., Bingham, Clifton O., Aassi, Maher, Bernasconi, Corrado
Publicado no Arthritis Care Res (Hoboken) (2015)

The increasing incidence of autoantibody negative RA is replicated and is partly explained by an aging population

Por Matthijssen, Xanthe M.E., Huizinga, Tom W.J., van der Helm-van Mil, Annette H.M.
Publicado no Ann Rheum Dis (2022)

Interleukin 10 secretion in relation to human IL-10 locus haplotypes

Por Eskdale, Joyce, Gallagher, Grant, Verweij, Cor L., Keijsers, Vivian, Westendorp, Rudi G. J., Huizinga, Tom W. J.
Publicado em 1998

Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis

Por Li, Wanying, Sasso, Eric H., van der Helm-van Mil, Annette H. M., Huizinga, Tom W. J.
Publicado no Rheumatology (Oxford) (2016)

MR signal intensity: staying on the bright side in MR image interpretation

Por Bloem, Johan L, Reijnierse, Monique, Huizinga, Tom W J, van der Helm-van Mil, Annette H M
Publicado no RMD Open (2018)

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the art...

Por van Dijk, Bastiaan T., Trouw, Leendert A., van der Helm-van Mil, Annette H. M., Huizinga, Tom W. J.
Publicado no Arthritis Res Ther (2020)

Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study

Por van Leeuwen, Nina M., Boonstra, Maaike, Huizinga, Tom W.J., Kaptein, Ad A., de Vries‐Bouwstra, Jeska K.
Publicado no Musculoskeletal Care (2020)